Home › Funds › Ikarian Capital, LLC › PTHS

Ikarian Capital, LLC position in PTHS

PELTHOS THERAPEUTICS INC · Health Care

Ikarian Capital, LLC reported holding 256,598 shares of PTHS (PELTHOS THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$7.3M, representing 1.16% of its reported portfolio and ranking #24 among its reported holdings. Ikarian Capital, LLC has disclosed PTHS holdings in 4 of the last 4 reported quarters, going back to Q3 2025.

Latest position (Q2 2026)256.60K sh
Reported value held$7.25M
Portfolio Weight1.16%
First reportedQ3 2025
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Ikarian Capital, LLC's PTHS position evolved

Ikarian Capital, LLC first disclosed a stake in PTHS in Q3 2025 at 62,451 shares (US$1.7M). The position peaked in Q4 2025 at 255,758 shares, worth US$7.9M. Across 4 filings, Ikarian Capital, LLC increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 2 time(s). The most recent filing (Q2 2026) shows 256,598 shares valued at US$7.3M. Notable position changes include a 310% increase in Q4 2025 (shares fell 32% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2025 62.45K $1.75M New
Q4 2025 255.76K $7.93M Add
Q1 2026 256.60K $5.39M Hold
Q2 2026 256.60K $7.25M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About PTHS and 13F data

PTHS (PELTHOS THERAPEUTICS INC) is a Health Care company. 23 other funds we track also report a position in PTHS — the largest reported positions include AIGH Capital Management LLC (US$9.3M), Murchinson Ltd. (US$8.6M), Knott David M Jr (US$624K). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding PTHS

All PTHS fund holders →

FAQ

How long has Ikarian Capital, LLC held PTHS?

Ikarian Capital, LLC has disclosed PTHS holdings in 4 of the last 4 reported quarters, going back to Q3 2025.

What is Ikarian Capital, LLC's current position in PTHS?

As of Q2 2026, Ikarian Capital, LLC holds 256.60K shares of PTHS (PELTHOS THERAPEUTICS INC), valued at $7.25M, representing 1.16% of its reported portfolio and ranking #24.

Has Ikarian Capital, LLC been buying or selling PTHS?

In the latest 13F filing (Q2 2026), Ikarian Capital, LLC held unchanged its position in PTHS. The position peaked in Q4 2025 at 255.76K shares.

Which other funds hold PTHS?

Other major institutional holders of PTHS include AIGH Capital Management LLC, Murchinson Ltd., Knott David M Jr, among 23 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.